Fundz

VolitionRx Limited Launches High Throughput Synthetic Sepsis Method to Aid Therapeutic Development for NETs-Related Diseases.

Feb 06, 2025
HendersonBiotechnologyHealth CareGeneticsTherapeutics

Product Description

VolitionRx Limited has announced its first commercial sale of a High Throughput Synthetic Sepsis method, facilitating real-time measurement of Neutrophil Extracellular Traps activation to support the development of new therapeutics for sepsis and NETs-related diseases.

Company Information

Company

VolitionRx

Location

Henderson, Nevada, United States

About

VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis.

Fundz sees it the moment VolitionRx ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Cameron hidden

hidden
hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for VolitionRx's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

VolitionRx shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.